I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Neuber first described autologous fat grafting (AFG) in 1893 for unilateral facial atrophy.\[[@ref1]\] With the continuous technical progress in the last century, there was an increased trend in replacement of soft tissue volume with AFG nowadays. However, assessment of the outcome after fat grafting has been criticized for lack of quantified evidence of fat graft survivability and predictability of volume restoration.\[[@ref2]\] Researchers demonstrated that lipoaspiration caused more initial damage than scraping, but may yield better long-term viability based on increased proliferation.\[[@ref3]\] Gir *et al*. compared various fat graft techniques into the following topics: fat harvesting, fat processing, fat reinjection and fat storage;\[[@ref4]\] and demonstrated there was no evidence supported one harvesting or processing technique above another as superior. Pu\[[@ref5]\] reviewed the studies related to fat grafting research, and one *in vivo* study shows that more adipose-derived stem cells are found within the fat of lower abdomen or inner thigh.\[[@ref6]\] In spite of the numerous clinical reports regarding fat graft technique, the specific techniques of graft harvesting, preparation and injection are still selected according to a surgeon\'s individual preference, since quantitative evidence of clinical fat survivability and predictability of volume restoration does not exist in spite of the evidence-based practice recommendations.\[[@ref7]\] The aim of this study was to provide an extensive study according to different recipient sites and fat graft survival rate (SR). The most severe complications of AFG are also summarized and critically reviewed.

M[ETHODS]{.smallcaps} {#sec1-2}
=====================

Literature search {#sec2-1}
-----------------

A comprehensive search of PubMed database to June 2013 was performed according to the guidelines of the American Society of Plastic Surgeons Fat Graft Task Force Assessment Methodology.\[[@ref7][@ref8]\] The following search terms were used to obtained all the related English-language literature: AFG, autogenous fat grafting, autologous fat transfer, autogenous fat transfer, autologous fat filler, autogenous fat filler, fat harvest, adipocyte harvest, lipoaspirate, lipotransfer, lipoinjection, lipoinfiltration, fat augmentation, adipose augmentation, adipocyte augmentation, and adipocyte graft.

Articles with full text accessible were further evaluated and addressing fat grafting with other types of grafts and for nonplastic surgery applications were excluded. Also excluded were non-English articles, reviews, case reports or case series \<10 patients. The inclusion and exclusion criteria are shown in [Figure 1](#F1){ref-type="fig"}.

![Flow chart of the study.](CMJ-128-1245-g001){#F1}

Data extraction {#sec2-2}
---------------

For each citation, data listed in [Table 1](#T1){ref-type="table"} (clinical articles) or [Table 2](#T2){ref-type="table"} (animal studies) was extracted. Reports were reviewed manually for patient demographics, operation related technique, and clinical outcomes. Studies with objective outcome efficacy as measured by tissue volume before and after filling treatment were calculated. All articles contained extractable data were analyzed. The data were pooled, and the fat SR was calculated. Reports of severe complications (with systemic manifestations and necessary medical intervention) were summarized according to the publication year, original country, fat inject area, inject volume, onset time and location of the complication, onset symptoms, final diagnosis, treatment and clinical outcomes as shown in [Table 3](#T3){ref-type="table"}.

###### 

Data extracted from clinical articles

  -----------------------------
  Patient characteristics
   Average age
   BMI
  Operation related technique
   Donor site
   Harvest technique
   Fat purifying method
   Recipient site
   Fat volume
   Supplementary procedures
   Injection technique
  Clinical outcome
   Follow-up time
   Measurement technique
   Complications
   Fat survival rate
  -----------------------------

BMI: Body mass index.

###### 

Data extracted from animal studies

  --------------------------
  Animal type
  Donor site
  Harvest technique
  Recipient site
  Fat purifying method
  Fat volume
  Supplementary procedures
  Injection technique
  Follow-up time
  Measurement technique
  Fat survival rate
  --------------------------

###### 

Severe complications of autologous fat grafting

  Year   Author               Country                Injection area                            Inject volume      Complication onset time   Onset symptom                                                        Diagnosis                                                               Treatment                                                   Outcome
  ------ -------------------- ---------------------- ----------------------------------------- ------------------ ------------------------- -------------------------------------------------------------------- ----------------------------------------------------------------------- ----------------------------------------------------------- -------------------------------------------------------------
  2012   David *et al.*       Canada                 Lateral aspect of nose                    N/A                90 min                    Vision loss                                                          Retinal artery embolism                                                 Lower intraocular pressure                                  Vision loss
  2011   Chang *et al.*       Korea                  Periocular                                N/A                2 h                       Vision loss, skin color change of the nose                           Ophthalmic artery and middle cerebral artery infarction                 Intravenous mannitolization                                 Vision loss
  2011   Keu *et al.*         Korea                  Breast                                    250 cc each side   1 day                     Erythema, tenderness                                                 Sepsis, multiple breast abscesses                                       Drainage, antibiotics                                       Recover with no deformity
  2011   Jun H                China                  Temporal area                             N/A                Immediately               Drowsy, aphasia, right hemiparesis                                   Middle cerebral artery occlusion                                        Mannitol, hydrocortisone, antiplatelet, hyperbaric oxygen   Function loss, National Institutes of Health Stroke Scale 6
  2011   Yoo *et al.*         Korea                  Forehead                                  N/A                1 day                     Swelling, vision loss, right hemiparesis                             Ophthalmic artery and middle cerebral artery infarction                 Methylprednisolone                                          Vision loss
  2011   James                United Arab Emirates   Earlobe                                   1 ml               9 weeks                   Tenderness, serous discharge in earlobes and thigh                   Atypical mycobacteria infection                                         Curettage, antibiotics                                      Hyperpigmentation
  2011   Sang *et al.*        Korea                  Nasal area                                N/A                Immediately               Pain and vision loss                                                 Ophthalmic artery occlusion                                             Pharmacomechanical thrombolysis                             Vision loss
  2011   Catherine *et al.*   UK                     Medial cheeks, temple                     35 ml              2 h                       Dizzy, progressive respiratory failure                               Pulmonary arteriole obstruction                                         Invasive ventilator support                                 Dearth
  2010   Simon *et al.*       US                     Breast and buttock                        100 ml             Several days              Erythema, pain                                                       Sepsis                                                                  Drainage                                                    Contour deformity
  2004   Olivier *et al.*     France                 Left face                                 17 ml              Immediately               Hypertonia, confusion                                                Bilateral anterior cerebral arteries embolism                           Reintubation                                                Mutism, paraplegia
  2003   Sung *et al.*        Korea                  Glabella                                  5 ml               1 min                     Mental change, hemiplegia                                            Internal carotid artery embolism                                        Artificial ventilation, dexamethasone                       Left eye necrosis then death
  2001   Helen *et al.*       US                     Nasolabial fold, lips, paranasal defect   6.5 ml             10 min                    Pain, disoriented, vision loss, hemiparesis                          Middle cerebral, ophthalmic, central retinal artery embolism            N/A                                                         Patchy necrosis, vision loss
  1998   Feinendegen          UK                     Nasolabial fold, lower lip, chin          N/A                7 h                       Global aphasia, hemiparesis                                          Left middle cerebral artery infarction, right retinal fundus embolism   N/A                                                         Fluent speech aphasia
                                                     Periorbital area                          N/A                Immediately               Eye pain, headache, unresponsive, right hemiplegia, global aphasia   Ophthalmic artery occlusion, deep venous thrombosis                     N/A                                                         Vision loss, able to walk, global aphasia
  1998   Jose                 Spain                  Breast                                    N/A                10 months                 Enlarged, painful lump                                               Liponecrotic pseudocyst                                                 Lumpectomy                                                  Recovered
  1997   Baumgartner          Switzerland            Nasolabial fold, lower lip and chin       N/A                7 h                       Global aphasia, hemiparesis                                          Right retinal artery embolism, left middle cerebral artery infarction   N/A                                                         N/A
  1996   Kyung                Korea                  Nasolabial fold                           0.5 ml             Immediately               Headache, dyspnea, unconscious                                       Ophthalmic artery, middle cerebral artery infarction                    Carbon dioxide and oxygen                                   Vision loss
  1993   Jose                 Spain                  Glabellar                                 N/A                During the procedure      Pain, vision loss, hemiplegia                                        Ophthalmic artery, middle cerebral embolism artery infarction           N/A                                                         Vision loss, partially function recovery
  1990   Vizcaino             Spain                  Breast                                    120 ml             Immediately               Enlarged lump                                                        Liponecrotic pseudocyst                                                 Surgical excision                                           Recovered
  1989   Neil                 US                     Forehead                                  N/A                Immediately               Headache, vision loss                                                Ophthalmic artery embolism                                              N/A                                                         Vision loss
  1988   Bahman               US                     Glabellar                                 N/A                During the procedure      Eye pain, vision loss                                                Retinal arterial occlusion                                              N/A                                                         Vision loss

N/A: Not applicable.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

The original search resulted in 550 articles with 416 in English. Totally, 122 reviews, 61 articles not related to plastic surgery, 29 articles without quantified measurement and 116 case reports with \<10 patients and 22 articles with data not extractable were excluded.

After the application of the exclusion/inclusion criteria, a total of 16 clinical studies and 10 animal research articles were included in this review \[[Figure 1](#F1){ref-type="fig"}\].

Animal research {#sec2-3}
---------------

Nude mice were used as the model to study human fat SR. Common recipient sites were dorsal area\[[@ref9][@ref10][@ref11]\] and scalp.\[[@ref12][@ref13]\] The SR varied from 38.3% to 57.84% with 4--15 weeks follow-up period, with the highest rate reported by Matsumoto *et al*. (57.84% after 4 weeks)\[[@ref10]\] and longest follow-up time reported by Shoshani *et al*. (51.5% after 15 weeks)\[[@ref12]\] without any intervention to the fat cells. Protocols to help the fat survive, such as insulin, adipose-derived stem cell, and hyperbaric oxygen, were given by different authors with a highest SR when grafted with adipose-derived stem cell reported by Matsumoto *et al*. (79.14% after 4 weeks).\[[@ref10]\] Rabbits were also commonly used for autologous fat SR. The donor sites included shoulder, inguinal, inter-scapular and groin area, and recipient sits included scalp, ear and rectus muscle. Autologous fat SR varied from 14.56% to 56% with 3--12 months follow-up period without any intervention. Epidermal growth factor, insulin, and other methods to increase fat SR have been studies on rabbit, with the highest SR reported by Fagrell *et al*.\[[@ref14]\] with fat cylinder transplantation (99% after 6 months) and longest follow-up time as 1-year reported by Viterbo *et al*.\[[@ref15]\] and Marques *et al*.\[[@ref16]\] (with a SR as 14.56% and 35%, respectively). Dogs were also studied by some researchers while only for vocal fold reconstruction.\[[@ref17][@ref18]\] Grafted fat volume varied from 0.5 ml to 2 ml, and the most commonly used operation method was Coleman\'s technique. Kruschewsky *et al*. performed the only three-dimensional objective fat volume measured experiment in 2007.\[[@ref17]\] They tested fat SR on canine vocal fold and performed magnetic resonance imaging (MRI) on the animal pre- and 3 months post-operation. However, the SR was only 18% if not combined with any intervention method.

Clinical studies {#sec2-4}
----------------

According to the 16 clinical studies included, fat SR varied from 15% to 83% with 6 months to 3.7 years of follow-up period in average. Zocchi and Zuliani reported the largest case series (181 patients) in 2008\[[@ref19]\] with the biggest volume of grafted fat (375 ml) in a single session. They combined AFG with mesenchymal stem cells and Brava technique in breast augmentation, and gained a SR as 55% at 1-year postoperation. Tanna *et al*.\[[@ref20]\] reported the highest fat SR as 83% in craniofacial microsomia soft-tissue reconstruction. However, the final result was achieved by 3--5 sessions' fat graft with 33 ml in average of each session. Intervention methods to increase fat SR included enhanced stromal vascular fraction\[[@ref21]\] (63% fat survived after 1-year), platelet-rich plasma\[[@ref21][@ref22]\] (69% and 77% fat survived after 1-year respectively), progenitor-supplemented adipose tissue\[[@ref23]\] (also named as cell-assisted lipotransfer, with 56% fat survived after 6 months), enriched cell culture medium\[[@ref24]\] (50--60% fat survived after 6 months), platelet rich fibrin\[[@ref22]\] (82% fat survived after 1-year), and mesenchymal stem cells\[[@ref19]\] (55% fat survived after 1-year). Khouri *et al*.\[[@ref25]\] reported the longest average follow-up time as 3.7 years in autologous fat breast augmentation patients with an average of 277 ml fat graft in one session. They also combined Brava technique with AFG in part of their patients and measured the result by MRI. The SR was 55% without Brava and 82% with Brava according to this prospective multicenter study. The most commonly used graft method is Coleman\'s technique, with frequently used donor sites as abdomen and thighs. The grafted fat volume varied from 50 ml to 375 ml in breast and 6--50 ml in the facial area.

Complications of autologous fat grafting {#sec2-5}
----------------------------------------

Multiple complications were reported in the literature, including infection, bleeding, calcification, fat necrosis, unspecified superficial lumps, less than expected beneficial outcome, fat embolism, systemic infection, etc. Totally, 21 severe complications of AFG were reported, including death (2), stroke (10), vision loss (11, 8 of which accompanied with stroke), sepsis (3), multiple abscess (1) and giant fat necrotic cyst (2). The details of included publications are listed in [Table 3](#T3){ref-type="table"}.

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

In 1987, the American Society of Plastic and Reconstructive Surgeons reported the problems and difficulties that have been encountered with autologous fat transplantation and concludes that only 30% of injected fat can be expected to survive for 1-year.\[[@ref26]\] Doubts have been expressed about the maintenance of the volume grafted and the possibility of determining the actual surviving volume.

Animal research {#sec2-6}
---------------

Measurement tools of fat SR in animals include weight, volume, computer image analysis, and dermal thickness. It still lacks of strong enough research evidence to measure fat SR in the subcutaneous tissue, no matter animal AFG or human fat graft on nude mice, due to the less quantified measurement pre- and postoperation.

Clinical studies {#sec2-7}
----------------

Few studies have addressed the issue of the rate of AFG absorption and the factors that may be associated with a higher or lower graft survival volume in the literature. Also, the mechanism of fat tissue survival and absorption is not fully understood. It is believed that fat tissue survives by nutrient diffusion from the serum within the first 48 h and then starts to regenerate.\[[@ref13]\]

The average percentage of fat obtained after each centrifugation was 70.1% without any significant difference in relation to the donor site.\[[@ref27]\] There is no evidence to support the belief that a specific donor site is optimal for a specific recipient site. Some authors also believed that the SR was related to the amount of fat injected in the certain volume, which caused the rapid increase in local tissue pressure.\[[@ref25]\] According to the included articles, the amount of autologous fat injected in the breast is 50--277 ml, and 1--33 ml in the facial area. However, there is no linear relation between the fat graft volume and SR according to the included studies, no matter where the recipient cite was.

It is believed that fat graft results are dependent on technique and surgeon expertise, also body weight fluctuations can affect graft volume over time.\[[@ref28]\] However, among the 16 included studies, only 3 of them mentioned the average body mass index (BMI) of patients, as 19.8, 23.5 and 19.7 respectively.\[[@ref25][@ref29][@ref30]\] One study used dual-energy X-ray absorptiometry scans during the screening visit and at weeks 24 and 48, to measure body fat variations throughout the follow-up period. The authors mentioned in the event that as body fat increased, facial improvement after infiltrations were considered with caution,\[[@ref31]\] but the results focused on patient satisfaction and improvement of quality of life without any quantified measurement. Further animal researches and clinical studies are required to demonstrate the correlation between BMI (as well as its variation pre- and post-AFG) and fat SR to reduce the bias of the results.

Mechanical washing of fat with ringer lactate is supported by studies that showed no damage to adipocyte integrity and protection of AFG from the negative action of hematic cells and components.\[[@ref32][@ref33]\] Also, low-pressure suction by means of larger bore cannulas, centrifugation with a force \<3000 r/min, and 2.5 mm diameter injection cannulas (compared with smaller diameter) with syringe aspiration were suggested.\[[@ref2][@ref4]\] Coleman is frequently cited for his description of a structural fat grafting technique.\[[@ref34]\] His success is attributed to a technique using 10-ml syringe fat harvest, isolation of fat by centrifugation, and 3-ml syringe injection of approximately 0.2 ml of fat in at least two directions per cannula pass. Coleman stresses that fat should be layered in many different levels, with limited parenchymal infiltration. This time-consuming technique (2 h for the first 100 ml of injections) and avoidance of "transplanting fat in large clumps" are reported to be critical to graft survival and prevention of fat necrosis and consequent infection. Thus, Coleman\'s technique is the most commonly performed method in both animal research and clinical studies reviewed in this article.

Researchers demonstrated that fat injection produces a considerable fat volume loss, which may be attributed to the partial fat liquefaction produced by the pressure of syringe.\[[@ref17]\] Thus, many articles are based on the principle that the volume placed in the syringe and presumably injected is the real volume may not be correct.

In regard to the method used to determine the initial and final volume of the graft, MRI has been established as the method of choice because of its excellent qualities for the study of fatty tissue.\[[@ref17]\] It is difficult to compare preoperative and postoperative photographs, even though they were taken with the same camera, same light, and the same distance.\[[@ref35]\] However, some authors argued that MRI was found to be not sensitive in determining breast volume and detecting defects in the superior and lateral periphery of the breast.\[[@ref36]\] Computed tomography (CT) scans can distinguish fat density from all other tissues and was chosen over MRI because CT measurements are more exact than those of MRI.\[[@ref37]\] Nguyen *et al*. observed the tissue sample at 9 months postfat injection and demonstrated that it was possible that fibrous connective tissues are the main components that maintain the bulk and tissue volume after long-term adipose tissue transplantation.\[[@ref38]\] Above all, a wide-accepted, objective, quantified method to confirm the fat volume is required during the study of AFG.

Complications {#sec2-8}
-------------

Chronic edema, calcification, fibrosis, acne, headache, dysesthesia, drooping, and irregularity after full-face fat injection were observed as moderate complications in most of the publications. The severe complications reviewed in this article happened in different decades \[[Figure 2](#F2){ref-type="fig"}\] and countries \[[Figure 3](#F3){ref-type="fig"}\] since the invention of AFG technique. Totally, 10 of these complications happened within 10 years, which is correlated with the rapid increasing number of publications \[[Figure 4](#F4){ref-type="fig"}\] and citations \[[Figure 5](#F5){ref-type="fig"}\] on this topic simultaneously according to the web of science. It is noticed that for the most severe complications such as vision loss and middle cerebral artery embolism, there was still lack of effective treatment and usually led to poor clinical outcomes.

![Publication decades of the severe complications related with autologous fat grafting.](CMJ-128-1245-g002){#F2}

![Original countries of the severe complications related with autologous fat grafting.](CMJ-128-1245-g003){#F3}

![Number of publications on the topic of autologous fat grafting in each year according to the web of science.](CMJ-128-1245-g004){#F4}

![Number of citations on the topic of autologous fat grafting in each year according to the web of science.](CMJ-128-1245-g005){#F5}

Other clinical applications of autologous fat grafting {#sec2-9}
------------------------------------------------------

Rigotti *et al*. have previously demonstrated clinical improvement of chronic radiation-induced fibrosis following injection of processed autogenous lipoaspirate beneath fibrotic skin.\[[@ref39]\] AFG was also widely used in laryngoplasy,\[[@ref40]\] dural defect repair,\[[@ref41]\] prostate-perineal fistula closure, and treating, etc.

The conclusion may not be drawn regarding the differences of fat long-term viability based on the donor site or recipient site. Despite the limited success and poor results in animal studies, the clinical result is optimistic. However, most of the clinical reports failed to objectively assess the outcomes. Longevity of grafted fat remains unknown, and additional treatments may be necessary to obtain more optimal results.
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